Cargando…
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
The in vitro deamination, cytotoxicity, cellular drug uptake, distribution and cellular pharmacology in HL-60 cells of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC), a lipophilic derivative of arabinofuranosylcytosine (ara-C), were studied. Compared with ara-C, NHAC in liposomal formulations...
Autores principales: | Horber, D. H., Schott, H., Schwendener, R. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033768/ https://www.ncbi.nlm.nih.gov/pubmed/7734320 |
Ejemplares similares
-
Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.
por: Horber, D. H., et al.
Publicado: (1995) -
Antitumor Activity and Pharmacology of 1‐β‐D‐Arabinofuranosylcytosine‐5′‐stearylphosphate: An Orally Active Derivative of 1‐β‐D‐Arabinofuranosylcytosine
por: Kodama, Kenjiro, et al.
Publicado: (1989) -
Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N(4)-octadecyl-1-β-D-arabinofuranosylcytosine in Daudi lymphoma cells
por: Koller-Lucae, S K M, et al.
Publicado: (1999) -
Monitoring of Intracellular l‐βD‐Arabinofuranosylcytosine 5′‐Triphosphate in 1‐β‐D‐Arabinofuranosylcytosine Therapy at Low and Conventional Doses
por: Yamauchi, Takahiro, et al.
Publicado: (2001) -
1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.
por: Muus, P., et al.
Publicado: (1991)